Beam Therapeutics Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Beam Therapeutics Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q1 2019 to Q4 2022.
  • Beam Therapeutics Inc. Operating Lease, Payments for the quarter ending December 31, 2022 was $5M, a 13.3% increase year-over-year.
  • Beam Therapeutics Inc. Operating Lease, Payments for the twelve months ending December 31, 2022 was $19.1M, a 66.2% increase year-over-year.
  • Beam Therapeutics Inc. annual Operating Lease, Payments for 2023 was $22.6M, a 18.6% increase from 2022.
  • Beam Therapeutics Inc. annual Operating Lease, Payments for 2022 was $19.1M, a 66.2% increase from 2021.
  • Beam Therapeutics Inc. annual Operating Lease, Payments for 2021 was $11.5M, a 65.9% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $19.1M $5M +$586K +13.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $18.5M $4.6M +$1.55M +50.5% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $16.9M $4.95M +$2.64M +114% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $14.3M $4.51M +$2.82M +168% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $11.5M $4.41M +$2.63M +148% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $8.83M $3.06M +$1.04M +51.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $7.79M $2.31M +$717K +45% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $7.07M $1.69M +$160K +10.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $6.91M $1.78M -$265K -13% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $7.18M $2.01M +$810K +67.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $6.37M $1.59M +$639K +67% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $5.73M $1.53M +$777K +104% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $4.95M $2.04M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $1.2M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $954K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $748K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.